JPS596638B2 - immobilized enzyme - Google Patents
immobilized enzymeInfo
- Publication number
- JPS596638B2 JPS596638B2 JP5576176A JP5576176A JPS596638B2 JP S596638 B2 JPS596638 B2 JP S596638B2 JP 5576176 A JP5576176 A JP 5576176A JP 5576176 A JP5576176 A JP 5576176A JP S596638 B2 JPS596638 B2 JP S596638B2
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- collagen
- acidic polysaccharide
- solubilized collagen
- immobilized enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108010093096 Immobilized Enzymes Proteins 0.000 title claims description 29
- 108010035532 Collagen Proteins 0.000 claims description 84
- 102000008186 Collagen Human genes 0.000 claims description 84
- 229920001436 collagen Polymers 0.000 claims description 84
- 102000004190 Enzymes Human genes 0.000 claims description 75
- 108090000790 Enzymes Proteins 0.000 claims description 75
- 229920001284 acidic polysaccharide Polymers 0.000 claims description 52
- 150000004805 acidic polysaccharides Chemical class 0.000 claims description 36
- 239000007864 aqueous solution Substances 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000011159 matrix material Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 150000007513 acids Chemical class 0.000 claims description 4
- 235000010418 carrageenan Nutrition 0.000 claims description 4
- 239000000679 carrageenan Substances 0.000 claims description 4
- 229920001525 carrageenan Polymers 0.000 claims description 4
- 229940113118 carrageenan Drugs 0.000 claims description 4
- 238000004132 cross linking Methods 0.000 claims description 4
- 229960000633 dextran sulfate Drugs 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 4
- 239000008394 flocculating agent Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229920001864 tannin Polymers 0.000 claims description 3
- 235000018553 tannin Nutrition 0.000 claims description 3
- 239000001648 tannin Substances 0.000 claims description 3
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 claims description 3
- 235000013311 vegetables Nutrition 0.000 claims description 3
- 229920003176 water-insoluble polymer Polymers 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 230000004931 aggregating effect Effects 0.000 claims 1
- 150000001299 aldehydes Chemical class 0.000 claims 1
- 230000005251 gamma ray Effects 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 59
- 238000000034 method Methods 0.000 description 19
- 229920001282 polysaccharide Polymers 0.000 description 15
- 239000005017 polysaccharide Substances 0.000 description 15
- 150000004804 polysaccharides Chemical class 0.000 description 13
- 239000012528 membrane Substances 0.000 description 11
- -1 etc. Polymers 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 8
- 229920002674 hyaluronan Polymers 0.000 description 8
- 229960003160 hyaluronic acid Drugs 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 description 6
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 6
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 108090000317 Chymotrypsin Proteins 0.000 description 5
- 229960002376 chymotrypsin Drugs 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000003100 immobilizing effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 4
- 229920001287 Chondroitin sulfate Polymers 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- 108010046334 Urease Proteins 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 239000000783 alginic acid Substances 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 229960001126 alginic acid Drugs 0.000 description 4
- 150000004781 alginic acids Chemical class 0.000 description 4
- 108010019077 beta-Amylase Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229940059329 chondroitin sulfate Drugs 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000004925 Acrylic resin Substances 0.000 description 3
- 229920000178 Acrylic resin Polymers 0.000 description 3
- 229920000856 Amylose Polymers 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 3
- 102100022624 Glucoamylase Human genes 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 241000978776 Senegalia senegal Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000009423 ventilation Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920002085 Dialdehyde starch Polymers 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000004195 Isomerases Human genes 0.000 description 2
- 108090000769 Isomerases Proteins 0.000 description 2
- 229920000715 Mucilage Polymers 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 229920001938 Vegetable gum Polymers 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- OEANUJAFZLQYOD-CXAZCLJRSA-N (2r,3s,4r,5r,6r)-6-[(2r,3r,4r,5r,6r)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](OC)O[C@H](CO)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O1 OEANUJAFZLQYOD-CXAZCLJRSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- 108010024976 Asparaginase Proteins 0.000 description 1
- 102000015790 Asparaginase Human genes 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108010003989 D-amino-acid oxidase Proteins 0.000 description 1
- 102000004674 D-amino-acid oxidase Human genes 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 108010028688 Isoamylase Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 108010073038 Penicillin Amidase Proteins 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010077465 Tropocollagen Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 229960003272 asparaginase Drugs 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940105657 catalase Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 239000012770 industrial material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229940072417 peroxidase Drugs 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000000051 wattle Anatomy 0.000 description 1
Landscapes
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
【発明の詳細な説明】
本発明は固定化酵素及びその製造方法に関し、更に詳細
には、コラーゲンー酸性多糖複合体を担体とする固定化
酵素およびその製造方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an immobilized enzyme and a method for producing the same, and more particularly to an immobilized enzyme using a collagen-acidic polysaccharide complex as a carrier and a method for producing the same.
本発明の目的はコラーゲンと酸性多糖との複合体生成作
用によって酵素を包括するか、コラーゲンー酸性多糖複
合体の水相性膨潤性を活用して、酵素との複合体を形成
せしめることによって酵素を包括することにより、コラ
ーゲンならびに酸性多糖の具備する諸特性を保有する有
用な固定化酵素を提供することである。The purpose of the present invention is to encapsulate enzymes by forming a complex between collagen and acidic polysaccharide, or by forming a complex with enzyme by utilizing the aqueous swelling property of the collagen-acidic polysaccharide complex. By doing so, it is an object of the present invention to provide a useful immobilized enzyme that possesses various properties possessed by collagen and acidic polysaccharides.
近年、酵素の利用に関する研究や技術が進歩すると共に
生化学の発展による酵素の作用機構の解明に伴って、新
しい酵素源の開発や、新しい酵素作用の応用技術の開発
が進められて来た。In recent years, as research and technology related to the use of enzymes have progressed, and with the elucidation of the mechanism of action of enzymes through the development of biochemistry, progress has been made in the development of new enzyme sources and new application technologies for enzyme action.
酵素の固定化の技術もその一つで、従来バッチ法によっ
ていた酵素反応の連続花を可能にし、酵素作用の著しい
特異性と反応効率を工業過程に提供するものとして注目
され、活発な研究が行われている。Enzyme immobilization technology is one such technology, and it has attracted attention as a technology that enables continuous enzymatic reactions, which were conventionally carried out by batch methods, and provides industrial processes with remarkable specificity and reaction efficiency of enzyme action, and is currently being actively researched. It is being done.
酵素の固定化方法についてはこれまで多くの方法が提案
されており、固定化によって酵素活性の安定度が増大す
ることや《つかえし使用が可能になるなどの利点が認め
られているが、反面、概して酵素活性が低下する方法が
多く、固定化処理中に失活したり、酵素の離脱や基質の
拡散滲透に影響をうけたり、場合によっては基質特異性
が変化することが知られている、又、調製技術が難しか
ったり、酵素の種類によってそれぞれに適当した方法の
開発が必要であったりして簡便で普遍的な方法は少いよ
うに見られる。Many methods have been proposed for enzyme immobilization, and it has been recognized that immobilization has advantages such as increasing the stability of enzyme activity and making it possible to use it as a refill. Generally, there are many methods that reduce enzyme activity, such as deactivation during immobilization, being affected by enzyme detachment or substrate diffusion, and in some cases, substrate specificity is known to change. Furthermore, there appear to be few simple and universal methods, as the preparation techniques are difficult and methods suitable for each type of enzyme must be developed.
一方、酵素を固定化するのに適当な担体としては、一般
的に言って、結合容量が太き《、担体表面の結合部位の
分布状態が適当であることが重要であって多孔度、電荷
の分布、親水性と疎水性の均衡など担体の組織の状態を
考慮する必要があり、さらに酵素活性におよぼす影響や
化学物、物理的な安定性等にも充分な配慮が必要である
。On the other hand, for a carrier suitable for immobilizing an enzyme, it is generally important to have a large binding capacity, and an appropriate distribution of binding sites on the surface of the carrier, as well as porosity and charge. It is necessary to consider the state of the structure of the carrier, such as the distribution of hydrophilicity and the balance between hydrophilicity and hydrophobicity, and also sufficient consideration must be given to the influence on enzyme activity, chemical substances, physical stability, etc.
このような観点からすると繊維性の蛋白質であるコラー
ゲンはすぐれた条件を兼ね備えた酵素の固定化材料と考
えられる。From this point of view, collagen, which is a fibrous protein, is considered to be an enzyme immobilization material that has excellent conditions.
本発明者は永年にわたりコラーゲンと酵素の関係につい
て研究しているものであるが、この研究に従事中、或る
種の酵素がコラーゲン溶液中で安定に保存されることを
観察していたことから、酵素の固定化の担体としてコラ
ーゲン溶液を用いることに着目するに至ったものである
。The present inventor has been researching the relationship between collagen and enzymes for many years, and while engaged in this research, he observed that certain enzymes were stably preserved in collagen solutions. This led to the focus on using a collagen solution as a carrier for enzyme immobilization.
コラーゲンは動物の結合組織の主成分で皮膚、骨、鍵等
に広く分布する蛋白質である。Collagen is a protein that is the main component of animal connective tissue and is widely distributed in the skin, bones, keys, etc.
このいわゆる「不溶性コラーゲン」の繊維を単分子状に
可溶化する方法は酸性領域の水中で蛋白質分解酵素を作
用させる特公昭37〜14426および特公昭37−1
3871号公報記載の方法がある他、糸状菌の酸性蛋白
質分解酵素を使用する特公昭44−11037および特
公昭44−1175号公報記載の方法もある。The method of solubilizing the fibers of this so-called "insoluble collagen" into a single molecule is to use a proteolytic enzyme in water in an acidic region.
In addition to the method described in Japanese Patent Publication No. 3871, there are also methods described in Japanese Patent Publication Nos. 44-11037 and 44-1175, which use acidic proteolytic enzymes of filamentous fungi.
また苛性ソーダ、硫酸ソーダおよび少量のアミンの存在
下で処理する特公昭46−15033号公報記載の方法
によっても可溶化される。It can also be solubilized by the method described in Japanese Patent Publication No. 46-15033, which involves treatment in the presence of caustic soda, sodium sulfate, and a small amount of amine.
以下、本発明においては前者によって可溶化されたコラ
ーゲンを「酵素可溶化コラーゲン」、後者によって可溶
化されたコラーゲンを「アルカリ可溶化コラーゲン」と
呼び、両者を併せて「可溶化コラーゲン」と呼ぶ。Hereinafter, in the present invention, collagen solubilized by the former method will be referred to as "enzyme-solubilized collagen," collagen solubilized by the latter method will be referred to as "alkali-solubilized collagen," and both will be referred to as "solubilized collagen."
上記の諸方法で得られる可溶化コラーゲン水溶液では、
いづれもコラーゲンが単分子分散の状態で溶解しており
、分子の長さは2800A,直径15A、分子量約30
万であり、3本のポリペプチド鎖が二重へリツクス状に
巻いている剛体棒状の形をとっていることが判明してい
る。In the solubilized collagen aqueous solution obtained by the above methods,
In both cases, collagen is dissolved in a monomolecularly dispersed state, the length of the molecule is 2800A, the diameter is 15A, and the molecular weight is approximately 30.
It has been found that the polypeptide chain has the shape of a rigid rod in which three polypeptide chains are wound in a double helix.
又、この溶液からほg天然のコラーゲン繊維に近い繊維
を再生させることができる。Furthermore, fibers similar to natural collagen fibers can be regenerated from this solution.
このような繊維形成能は酵素の固定化に際して極めて有
効に作用して、酵素の包括を強固にし、しかも適当な強
度をもった種々の形態、即ち糸状、膜状等に成型するこ
とを容易にする。Such fiber-forming ability acts extremely effectively when immobilizing enzymes, solidifying the entrapment of enzymes, and making it easy to mold them into various shapes with appropriate strength, such as threads and membranes. do.
尚、コラーゲンは親水性であって、しかも両性電解質と
しての性質を持っている。Note that collagen is hydrophilic and has properties as an amphoteric electrolyte.
酵素の担体として利用する場合には、とくにこの性質が
重要であってpHによりカチオン、アニオンのいづれの
電荷をも利用することができる。This property is particularly important when used as a carrier for enzymes, and both cationic and anionic charges can be used depending on the pH.
即ち、酵素可溶化コラーゲンはpH 7〜9付近、アル
カリ可溶化コラーゲンはpH4.6付近で繊維状の沈澱
を生ずるが、さらに両方のコラーゲンを混合する場合に
は、両者の比率に対応して、両者の等電点の間の種々の
pHの等電点を持ちそのpH下で繊維状の沈澱を生せし
めることができる。That is, enzyme-solubilized collagen produces fibrous precipitates at around pH 7 to 9, and alkali-solubilized collagen at around pH 4.6, but when both types of collagen are mixed, depending on the ratio of the two, It has isoelectric points at various pH values between the two isoelectric points, and can form fibrous precipitates under these pH values.
又、アンモニア、苛性ソーダ等による中和や界面活性剤
、有機溶媒の添加によっても繊維形成が可能であり、中
性塩を添加しても沈澱を生成する。Fiber formation is also possible by neutralization with ammonia, caustic soda, etc., or by addition of a surfactant or organic solvent, and even if a neutral salt is added, a precipitate is formed.
さらに濃厚塩類溶液又は有機溶媒中に押出すと可溶化コ
ラーゲンは凝固し、脱水されて任意の形状に成型される
。When further extruded into a concentrated salt solution or an organic solvent, the solubilized collagen coagulates, is dehydrated, and molded into any desired shape.
尚、コラーゲンと酵素の結合機構はなお充分明かではな
いが、コラーゲンと酵素とのイオン結合が一つの重要な
因子であると考えられる。Although the bonding mechanism between collagen and enzymes is still not fully clear, ionic bonding between collagen and enzymes is thought to be one important factor.
さらに可溶化コラーゲン水溶液はコラーゲンが単分子状
態で溶解しているために酵素との接触が不溶性コラーゲ
ン分散液よりも充分に行われることが、コラーゲンと酵
素の結合を効率よくしている要因であると考えられる。Furthermore, in the solubilized collagen aqueous solution, since the collagen is dissolved in a monomolecular state, contact with the enzyme is more thorough than in the insoluble collagen dispersion, which is a factor that makes the binding between collagen and enzyme more efficient. it is conceivable that.
本発明者は酵素を固定化するに当って、蛋白質が酸性多
糖と複合体を形成することに着目して、コラーゲンと親
和性をもつ多糖との相互作用に検討を加え、両者の特異
な親和力を活用して酵素を効果的に固定化することを企
図するに至った。When immobilizing enzymes, the present inventors focused on the fact that proteins form complexes with acidic polysaccharides, and investigated the interaction between collagen and polysaccharides that have affinity, and discovered that the unique affinity between the two. We came up with a plan to effectively immobilize enzymes by utilizing this.
多糖は動植物界に広く分布している物質であるが、その
うちでもいわめる酸性ムコ多糖は動物の結合組織におい
て特定の蛋白質と結合してムコ多糖一蛋白複合体として
繊維間ならびに細胞間に存在し、繊維や細胞の配列構成
にあづかっている。Polysaccharides are substances that are widely distributed in the animal and plant kingdom, and among them, acidic mucopolysaccharides are present in the connective tissues of animals as mucopolysaccharide-protein complexes that bind to specific proteins between fibers and cells. It also deals with the arrangement and composition of fibers and cells.
即ちこれらの複合体はそれぞれの組織でコラーゲンと共
に特徴のある高次繊維構造をとって重要な生埋作用を担
っている。That is, these composites, together with collagen, assume a characteristic higher-order fibrous structure in each tissue and play an important bioembedding function.
又、体液成分としても、これら複合体の弱い水相力やア
ニオンとしての特異的な親和性によって細胞外液の容量
調節や水分の保持、陽イオンの移動に関与している。Furthermore, as a component of body fluids, these complexes are involved in regulating the volume of extracellular fluid, retaining water, and transporting cations due to the weak aqueous force and specific affinity as anions of these complexes.
コンドロイチン硫酸は化骨に関与し、デルマタン硫酸一
蛋白複合体は組織におけるトロポコラーゲンの繊維化の
引き金役として、ヒアルロン酸一蛋白複合体は関節の滑
剤として、ヘパIJ 7は抗トロンビン作用に基く血液
凝固の作用物質として、それぞれ重要な役割を果してい
る。Chondroitin sulfate is involved in bone formation, dermatan sulfate-protein complex triggers fibrosis of tropocollagen in tissues, hyaluronic acid-protein complex acts as a lubricant for joints, and hepa IJ 7 has an antithrombin effect. Each plays an important role as an agent of blood coagulation.
又、キチンは無脊椎動物の骨格構造を形成して生体防護
の役割を果している。Furthermore, chitin forms the skeletal structure of invertebrates and plays a protective role.
さらに糖蛋白は或る種の酵素の安定度に関係があること
も推定されている。Furthermore, it is assumed that glycoproteins are involved in the stability of certain enzymes.
一方、植物体においては酸性多糖が細胞壁、細胞間多糖
として細胞の構成にあづかり、その支持と防護の役割を
果しているし、細胞のイオンの吸収に相関をもつことも
推定されている。On the other hand, in plants, acidic polysaccharides participate in the structure of cells as cell walls and intercellular polysaccharides, play a supporting and protective role, and are also presumed to have a correlation with the absorption of ions by cells.
ペクチン、ヘミセルロースがセルロースを支持体として
その周辺を充填しているし、アルギン酸は褐藻の細胞壁
多糖として存在する。Pectin and hemicellulose fill the periphery of cellulose as a support, and alginic acid exists as a cell wall polysaccharide of brown algae.
さらに、天然の多糖のあるものは化学処理され(例えば
カルボキシメチルセルロース、カルボキシメチルアミロ
ース、カルボキシメチル澱粉、デキストラン硫酸)、糊
料、添加剤、懸濁剤として又、医療、薬剤、製紙、繊維
、写真等の工業材料として利用されている。In addition, some natural polysaccharides are chemically treated (e.g. carboxymethyl cellulose, carboxymethyl amylose, carboxymethyl starch, dextran sulfate) and used as thickeners, additives, suspending agents, and in medical, pharmaceutical, paper, textile, and photographic applications. It is used as an industrial material.
上記した多糖類のうち、アラビアゴム等のへテログリカ
ン、アルギン酸やペクチン酸等のグリクロナン、ヒアル
ロン酸やコンドロイチン硫酸等のムコ多糖類ならびにカ
ルボキシメチルセルロース等のホモグリカンのカルボキ
シメチル誘導体等は適当な条件の下でコラーゲンと非常
によ《結合して、コラーゲンと多糖の複合体を形成する
。Among the polysaccharides mentioned above, heteroglycans such as gum arabic, glycuronans such as alginic acid and pectic acid, mucopolysaccharides such as hyaluronic acid and chondroitin sulfate, and carboxymethyl derivatives of homoglycans such as carboxymethylcellulose can be used under appropriate conditions. It combines very well with collagen to form a collagen-polysaccharide complex.
本発明では多糖類のうち、コラーゲンと親和性が強《、
コラーゲンと複合体を形成する多糖を以下酸性多糖とよ
ぷ。In the present invention, among polysaccharides, collagen has a strong affinity.
Polysaccharides that form complexes with collagen are referred to as acidic polysaccharides.
本発明で使用される酸性多糖としては次のようなものが
あげられる。The acidic polysaccharides used in the present invention include the following.
ヘテログリカン:アラビャゴムや植物ゴム及び粘質物等
、クリクロナン:アルギン酸、ペクチン質等、ムコ多糖
:ヒアルロン酸、コンドロイチン硫酸、ヘパリン及び
Rhizoblum属の莢膜多糖など微生物の生産する
多糖その他、ホモグリカンの誘導体二カルボキシルメチ
ルセルロース、カルボキシルメチルスターチ、カルボキ
シルメチルアミロース等、その他:デキストラン硫酸、
カラゲナン、高分子酸等である。Heteroglycans: gum arabic, vegetable gums, mucilage, etc., criclonan: alginic acid, pectin, etc., mucopolysaccharide: hyaluronic acid, chondroitin sulfate, heparin, capsular polysaccharide of Rhizoblum, etc., polysaccharides produced by microorganisms, and other homoglycan derivatives dicarboxyl Methyl cellulose, carboxyl methyl starch, carboxyl methyl amylose, etc. Others: dextran sulfate,
These include carrageenan and polymeric acids.
上記した酸性多糖は一種でもまた二種以上の組み合わせ
で使用することが可能であるし、これ以外の高分子物質
も添加することができる。The above acidic polysaccharides can be used alone or in combination of two or more, and other polymeric substances can also be added.
これらの酸性多糖はアニオンとしての特異な親和性を持
っているし、一方、コラーゲンはその両性電解質として
の性質から、その等電点より低い酸性側のpHO下では
正に荷電された状態で存在する。These acidic polysaccharides have a unique affinity as anions, while collagen exists in a positively charged state under acidic pH lower than its isoelectric point due to its ampholyte properties. do.
従って適当なpHを選ぶとコラーゲンと酸性多糖とは極
めてよく結合して凝集沈澱を生ずる。Therefore, if an appropriate pH is selected, collagen and acidic polysaccharides combine extremely well to form agglomerated precipitates.
このコラーゲンと酸性多糖との複合体は上記したような
コラーゲンの特質に加えて、さらに多糖の特質である高
い親水性や粘性、弾性、皮膜形成能、保護コロイド性、
接着性等が加味されるので、担体として極めて有利な特
徴を付与することが可能である。In addition to the above-mentioned properties of collagen, this complex of collagen and acidic polysaccharide has the properties of polysaccharide such as high hydrophilicity, viscosity, elasticity, film-forming ability, and protective colloidal properties.
Since adhesive properties and the like are taken into consideration, it is possible to impart extremely advantageous characteristics as a carrier.
この場合、目的に応じて条件をかえてその結合量を調節
したり、適当に架橋処理を加えるなどの手段を併用する
ことにより、強度を向上させ、その他の物性を適宜調整
し得るので、酵素の固定化に適した担体を提供すること
ができるのである。In this case, it is possible to improve the strength and adjust other physical properties as appropriate by adjusting the binding amount by changing the conditions or by adding appropriate cross-linking treatment depending on the purpose. Therefore, it is possible to provide a carrier suitable for immobilization of .
本発明の方法は上記の諸知見に基いて、コラーゲンと酸
性多糖との親和力によって生成される複合体のマトリッ
クスの中に酵素を包括固定させるものである。The method of the present invention is based on the above-mentioned findings, and involves enclosing and immobilizing enzymes in a complex matrix produced by the affinity between collagen and acidic polysaccharide.
即ち、本発明は対象とする酵素液とその活性の安定pH
領域において、陽荷電の状態にある可溶化コラーゲンの
水溶液及び酸性多糖の水溶液の三者を酵素の解離状態を
配慮した適当なpH値の下で混合することにより、酵素
を包括した複合体を形成させる。That is, the present invention aims to improve the target enzyme solution and the stable pH of its activity.
A complex containing the enzyme is formed by mixing a positively charged aqueous solution of solubilized collagen and an aqueous solution of acidic polysaccharide at an appropriate pH value that takes into account the dissociation state of the enzyme. let
次いで得られた複合体を脱水、乾燥させ、成型すること
よりなる酵素の固定化方法、ならびに、あらかじめ陽荷
電の状態にある可溶化コラーゲンの水溶液と酸性多糖の
水溶液を適当したpH値の下で混合することにより、コ
ラーゲン・酸性多糖複合体を形成させた後、この複合体
を必要に応じ硬化処理を行い、脱水、乾燥させ、成型す
る。Next, the enzyme immobilization method consists of dehydrating, drying and molding the obtained complex, and an aqueous solution of solubilized collagen and an aqueous solution of acidic polysaccharide, which are in a positively charged state in advance, are mixed at an appropriate pH value. After mixing to form a collagen/acidic polysaccharide complex, this complex is subjected to a curing treatment as required, dehydrated, dried, and molded.
この成型物を膨潤せしめ、次いで対象とする酵素液中に
浸漬することによって、酵素をコラーゲン・酸性多糖複
合体のマトリックス中に包括せしめた後、水洗、乾燥す
ることよりなる酵素の固定化方法である。This molded product is swollen and then immersed in a target enzyme solution to encapsulate the enzyme in a matrix of collagen/acidic polysaccharide complex, followed by washing with water and drying. be.
以下に具体的態様をあげて説明する。Specific aspects will be described below.
対象とする酵素の安定pH領域のpHに調製した酵素液
に酵素可溶化コラーゲン及び/またはアルカリ可溶化コ
ラーゲンの水溶液及び酸性多糖溶液をその混合液のpH
がそれぞれのコラーゲンの等電点以下のpHあるいは沈
澱pH以下になるように調節しながら攪拌下に除々に添
加する。An aqueous solution of enzyme-solubilized collagen and/or alkali-solubilized collagen and an acidic polysaccharide solution are added to the enzyme solution adjusted to a pH in the stable pH range of the target enzyme.
is gradually added under stirring while adjusting the pH to be below the isoelectric point of each collagen or below the precipitation pH.
添加するコラーゲン量と酵素量の乾燥重量に基く割合は
前者100部に対して後者10〜500部程度でコラー
ゲン濃度は1係以下の水溶液として使用するのが適当で
あるが、目的とする成型方法によって変えることができ
る。The ratio of the amount of collagen and enzyme to be added based on dry weight is about 10 to 500 parts of the latter to 100 parts of the former, and it is appropriate to use it as an aqueous solution with a collagen concentration of 1 part or less, but it is suitable for the intended molding method. can be changed by
酸性多糖の添加量はコラーゲン100部に対し1〜40
部程度が良好で、その溶液の濃度が2.5係以下の溶液
として使用するのがよい。The amount of acidic polysaccharide added is 1 to 40 parts per 100 parts of collagen.
It is preferable to use the solution as a solution with a good concentration and a concentration of 2.5 parts or less.
混合液は所定のpHに保つように充分注意して調整し、
攪拌をつづけると酵素を包括したコラーゲンー酸性多糖
複合体が凝集生成する。Adjust the mixed solution carefully to maintain the specified pH.
If the stirring is continued, the collagen-acidic polysaccharide complex containing the enzyme will be aggregated.
凝集生成物の析出が完結し、これらが均一に分散した後
、脱水、乾燥、成型すればコラーゲンー酸性多糖のマト
リックスに酵素が包括された固定化酵素が得られる。After the precipitation of the aggregated products is completed and they are uniformly dispersed, they are dehydrated, dried, and molded to obtain an immobilized enzyme in which the enzyme is enclosed in a collagen-acidic polysaccharide matrix.
この場合、混合液のpHは酵素可溶化コラーゲンではp
H7.0付近以下、アルカリ可溶化コラーゲンではpH
4.6以下両者のコラーゲンの混合液ではその量比によ
ってきまる沈澱pH以下とするのが適当である。In this case, the pH of the mixture is p
H7.0 or lower, pH for alkaline solubilized collagen
4.6 or less In a mixed solution of both collagens, it is appropriate that the precipitation pH is determined by the ratio of their amounts.
複合体生成に好適なpHは用いる酸性多糖の種類及びそ
の濃度ならびにコラーゲンと酸性多糖の量比によって異
なるし、さらに酵素蛋白質の解離の状態もpHに依存す
るから、混合液のpHはこの点にも配慮して、酵素蛋白
質とコラーゲン、酸性多糖の電荷が当量に存在するよう
に混合比やpHを調整することが好ましい。The pH suitable for complex formation varies depending on the type of acidic polysaccharide used, its concentration, and the ratio of collagen to acidic polysaccharide, and the state of dissociation of the enzyme protein also depends on the pH, so the pH of the mixed solution should be adjusted based on this point. Taking this into account, it is preferable to adjust the mixing ratio and pH so that the charges of the enzyme protein, collagen, and acidic polysaccharide are present in equivalent amounts.
従って、あらかじめ好適な凝集沈澱の生成条件を設定し
てから実施すれば三者の親和性、凝集性を高度に発揮さ
せ、効果的に固定することができる。Therefore, if suitable coagulation and precipitate formation conditions are set in advance and then carried out, the affinity and cohesiveness of the three components can be exhibited to a high degree, and the coagulation can be effectively fixed.
又、使用するコラーゲンと酸性多糖はその酸性多糖の種
類と濃度によって、種々の割合で用いることが出来るの
で、酸性多糖の種類と量比をかえることによって、それ
ぞれに特有の性質を反映しして種々の特性を有する固定
化酵素を得ることができる。In addition, the collagen and acidic polysaccharide used can be used in various ratios depending on the type and concentration of the acidic polysaccharide, so by changing the type and amount ratio of the acidic polysaccharide, the unique properties of each can be reflected. Immobilized enzymes with various properties can be obtained.
本発明で、使用される酸性多糖としては次のようなもの
があげられる。In the present invention, the following acidic polysaccharides can be used.
ヘテログリカン:アラビャゴムや植物ゴム及び粘質物等
、グリクロナン:アルギン酸、ペクチン質等、ムコ多糖
:ヒアルロン酸、コンドロイチン硫酸、ヘパリン及びR
hizobium属の莢膜多糖など微生物の生産する多
糖その他、ホモグリカンの誘導体:カルボキシルメチル
セルロース、カルボキシルメチルスターチ、カルボキシ
ルメチルアミロース等、その他:デキストラン硫酸、カ
ラゲナン、高分子酸等である。Heteroglycans: gum arabic, vegetable gums, mucilages, etc., glycuronan: alginic acid, pectin, etc., mucopolysaccharides: hyaluronic acid, chondroitin sulfate, heparin, and R
These include polysaccharides produced by microorganisms such as capsular polysaccharides of the genus Hizobium, homoglycan derivatives such as carboxylmethyl cellulose, carboxylmethyl starch, and carboxylmethyl amylose; others such as dextran sulfate, carrageenan, and polymeric acids.
上記した酸性多糖は一種でもまた二種以上の組み合わせ
で使用することが可能であるし、これ以外の高分子物質
も添加することができる。The above acidic polysaccharides can be used alone or in combination of two or more, and other polymeric substances can also be added.
一方、あらかじめ陽荷電の状態にある可溶化コラーゲン
、即ち酵素可溶化コラーゲンではpH7.0付近以下、
アルカリ可溶化コラーゲンではpH4.6以下の水溶液
に酸性多糖の水溶液゜を攪拌下に添加混合し、所定のp
Hに攪拌をつづけてコラーケン−酸性多糖複合体を形成
させ、均一 になってから必要に応じて硬化処理を併用
して脱水、乾燥、成型する。On the other hand, solubilized collagen that is positively charged in advance, that is, enzyme-solubilized collagen, has a pH of around 7.0 or lower.
For alkaline solubilized collagen, an aqueous solution of acidic polysaccharide is added to an aqueous solution with a pH of 4.6 or less with stirring, and the mixture is adjusted to a predetermined pH.
Continue to stir the mixture to form a Kolaken-acidic polysaccharide complex, and after it becomes homogeneous, dehydrate, dry, and mold using curing treatment if necessary.
コラーゲン溶液、酸性多糖溶液の濃度、両者の混合比、
pHは原則的に前記に準じて実施する。Concentrations of collagen solution and acidic polysaccharide solution, mixing ratio of both,
The pH is determined in principle in the same manner as described above.
得られたコラーゲンー酸性多糖の成型物を水中の適当な
pHO下で極力膨潤せしめ、次いでその安定pH領域に
ある対象とする酵素液中に浸漬する。The resulting collagen-acidic polysaccharide molded product is swollen as much as possible in water at an appropriate pH, and then immersed in the target enzyme solution in its stable pH range.
10℃以下で2時間乃至20時間程度浸漬し、酵素を結
合せしめた後、蒸溜水あるいは適当な緩衝液を用いて充
分洗滌するか、さらに乾燥することによっても、コラー
ゲンー多糖複合体のマトリックス中に包括された固定化
酵素が得られる。After soaking at 10°C or less for about 2 to 20 hours to bind the enzyme, it can be thoroughly washed with distilled water or an appropriate buffer, or further dried to form a matrix of collagen-polysaccharide complex. An entrapped immobilized enzyme is obtained.
以上の操作は酵素可溶化コラーゲンを使用する場合には
25℃、アルカリ可溶化コラーゲンを用いる場合には2
0℃以下で実施する。The above operations are carried out at 25°C when using enzyme-solubilized collagen, and at 25°C when using alkali-solubilized collagen.
Perform at 0°C or below.
次に、上記のようにして得られた固定化酵素を必要に応
じて、さらに強固に固定するためには次の処理を併用す
ることができる。Next, in order to further firmly immobilize the immobilized enzyme obtained as described above, the following treatment can be used in combination, if necessary.
(I) 酵素とコラーゲンならびに酸性多糖を混合し
て酵素を包括した後に、この混合液中にさらにコラーゲ
ンー酸性多糖複合体に作用する下記の・物質の水溶液を
乾燥重量に基き、コラーゲン100部に対し1〜50部
程度を攪拌しつつ添加してから、脱水、乾燥するか、未
処理の固定化酵素を乾燥後の段階で、これらの0.05
%乃至5.0係の水溶液で処理した後乾燥する。(I) After mixing the enzyme, collagen, and acidic polysaccharide to enclose the enzyme, add an aqueous solution of the following substances that act on the collagen-acidic polysaccharide complex to this mixed solution, based on dry weight, per 100 parts of collagen. After adding about 1 to 50 parts with stirring, dehydrate and dry, or add 0.05 parts of these to the untreated immobilized enzyme after drying.
After treatment with an aqueous solution of 5.0% to 5.0%, it is dried.
(1)アルデヒド基を有する架橋剤であるジアルデヒド
澱粉やグルタールアルデヒド等 (2)植物性タンニン
揉剤であるワットル、チェスナット、タンニン酸等、(
3)クロム、鉄、アルミニウム等の3価の金属の塩類、
(4)合成揉剤であるナフタレン、アンスラセン、ベ
ンゼン、フェノール類、リクニンスルホン酸などの縮合
物ニスルホン基を導入したもの、
(5)チオ硫酸塩など、 (6)高分子凝集剤であるポ
リアクリル酸ナトリウムやポリアクリル酸アミドの部分
加水分解物等、
■ 酵素とコラーゲンならびに酸性多糖の混合液を含氷
状態のま又で、常温以下で紫外線やγ線を照射して、架
橋強化処理を行った後、脱水、乾燥する。(1) Crosslinking agents with aldehyde groups such as dialdehyde starch and glutaraldehyde (2) Vegetable tannin scrubbing agents such as wattle, chestnut, tannic acid, etc.
3) Salts of trivalent metals such as chromium, iron, aluminum, etc.
(4) Synthetic massaging agents such as naphthalene, anthracene, benzene, phenols, and condensates such as likuninsulfonic acid. (5) Thiosulfates, etc.; (6) Polymer flocculants such as Partial hydrolysates of sodium acrylate and polyacrylic acid amide, etc. ■ A mixed solution of enzymes, collagen, and acidic polysaccharides is irradiated with ultraviolet rays and gamma rays at room temperature or below in an iced state to strengthen crosslinking. After that, dehydrate and dry.
紫外線照射は30Wの紫外線灯の場合、5〜30Crn
の距離から5〜30分間の照射が適当であり、γ線の照
射量は全線量で0.1〜10Mγ(メガレントゲン)が
適肖である。Ultraviolet irradiation is 5 to 30Crn when using a 30W ultraviolet lamp.
It is appropriate to irradiate from a distance of 5 to 30 minutes, and the total dose of γ-rays is 0.1 to 10 Mγ (megaroentgen).
(ト)脱水乾燥して得られた固定化酵素を40°〜60
℃で加熱処理する。(G) The immobilized enzyme obtained by dehydration and drying is heated at 40° to 60°
Heat treatment at ℃.
(自)脱水乾燥して得られた固定化酵素を、さらに水不
溶性高分子物質を溶解させた有機溶媒中、例えばMセル
ローズのメチレンクロライド溶液に分散させた後、乾燥
成型する。The immobilized enzyme obtained by (auto) dehydration and drying is further dispersed in an organic solvent in which a water-insoluble polymer substance is dissolved, such as a methylene chloride solution of M cellulose, and then dried and molded.
以上の処理方法は相互に併用することができる。The above processing methods can be used together.
又、コラーゲンー酸性多糖複合体を酵素液に浸漬する方
法をとる場合においては担体として使用するコラーゲン
ー酸性多糖複合体を強化するために、その工程に上記の
処理を併用することもできる。Further, when a method of immersing the collagen-acidic polysaccharide complex in an enzyme solution is used, the above-mentioned treatment can be used in combination with the process in order to strengthen the collagen-acidic polysaccharide complex used as a carrier.
尚、本発明においてはフイルム状、糸状、スポンヂ状、
粒状、ブロック状等、所望の形状に酵素を固定化できる
ことは言うまでもない。In addition, in the present invention, film-like, thread-like, sponge-like,
It goes without saying that the enzyme can be immobilized in any desired shape, such as granules or blocks.
以上の如く、本発明によって得られる固定化酵素は強い
酵素活性を示すと同時に、コラーゲンの種々の特性に加
えて、使角する酸性の種類、混合量比によって、それぞ
れに特有の性質を併有しているし、各種の酵素を容易に
固定化することができる。As described above, the immobilized enzyme obtained by the present invention exhibits strong enzymatic activity, and at the same time has unique properties depending on the type of acid used and the mixing ratio in addition to the various properties of collagen. and various enzymes can be easily immobilized.
本発明を実施することによって、例えば酵素反応を連続
化することが可能で各種の工業過程に応用される他、連
続自動分析や種々の医療分野などに応用することができ
る。By carrying out the present invention, it is possible to make enzyme reactions continuous, for example, and it can be applied to various industrial processes, as well as continuous automatic analysis and various medical fields.
尚、本発明により二種類以上の酵素を同時に固定化する
ことも勿論可能である。Incidentally, according to the present invention, it is of course possible to immobilize two or more types of enzymes at the same time.
さらに以下の実施例では一部の酵素の固定化方法につい
て記載したものであるが、グリコアミラーゼ、α−アミ
ラーゼ、β−アミラーゼ、プルラナーゼ、イソアミラー
ゼ、インベルターゼ、セルラーゼ、ガラク1・シダーゼ
、イソメラーゼ、リゾチーム、ペクチナーゼ、ヒアルロ
ニダーゼやトリプシン、キモトリプシンプラスミン等の
グロテアーゼ類の他、ウレアーゼ、リパーゼ、ペニシリ
ンアミダーゼ、アシラーゼ、リボヌクレアーゼ、ウリカ
ーゼ、アスパラギナーゼ、ストレプトキナーゼ、ウロキ
ナーゼ、トロンビン、グルコースオキシダーゼ、カタラ
ーゼ、パーオキシダーゼ、d−アミノ酸オキシダーゼ等
加水分解酵素、異性化酵素、酸化還元酵素、転移酵素、
合成酵素、リアーゼに属する多種類の酵素の固定化も同
様の技術手段によって達成される。Furthermore, the following examples describe methods for immobilizing some enzymes, including glycoamylase, α-amylase, β-amylase, pullulanase, isoamylase, invertase, cellulase, galac-1-sidase, isomerase, and lysozyme. , pectinase, hyaluronidase, trypsin, chymotrypsin plasmin and other groteases, urease, lipase, penicillin amidase, acylase, ribonuclease, uricase, asparaginase, streptokinase, urokinase, thrombin, glucose oxidase, catalase, peroxidase, d-amino acid oxidase isohydrolase, isomerase, oxidoreductase, transferase,
Immobilization of various enzymes belonging to synthetic enzymes and lyases can also be achieved by similar technical means.
以下の実施例に示す酵素活性の単位は次の通り定義され
る。The units of enzyme activity shown in the Examples below are defined as follows.
即ち、プロテアーゼは30℃、1分間に生成するチロシ
ンμg数;ウレアーゼは30℃、1分間に生成するアン
モニア態窒素のμg数;グルコアミラーゼは40℃、1
分間においてグルコース100μgを生成する活性;β
−アミラーゼ、は3・0℃1分間においてグルコース1
00μgに相当する還元力を生成する活性である。That is, for protease, the number of micrograms of tyrosine produced per minute at 30°C; for urease, the number of micrograms of ammonia nitrogen produced per minute at 30°C; for glucoamylase, the number of micrograms of ammonia nitrogen produced per minute at 30°C;
Activity to produce 100 μg of glucose per minute; β
-Amylase, glucose 1 in 1 minute at 3.0℃
The activity is to generate a reducing power equivalent to 00 μg.
実施例 1
キモトリプシン、ウレアーゼ各400■を90mlの蒸
溜水に溶解し、それぞれ別の容器に入れて攪拌してpH
を5.0に保ちながら、酵素可溶化コラーゲンの1係水
溶液100mlを加える。Example 1 400 μl each of chymotrypsin and urease were dissolved in 90 ml of distilled water, and each was placed in a separate container and stirred to adjust the pH.
Add 100 ml of an aqueous solution of enzyme-solubilized collagen while maintaining the pH at 5.0.
これらの混合液をさらに充分に攪拌してpHを0.5に
保ちながら、カルボキシメチルセルロースの1係水溶液
10mlを除々に添加する。While stirring these mixtures sufficiently to maintain the pH at 0.5, 10 ml of a 1-H aqueous solution of carboxymethylcellulose is gradually added.
か《して、各々の酵素を包括したコラーゲン、カルボキ
シメチルセルロース複合体の繊維状の凝集沈澱が液中に
分散する。In this way, a fibrous aggregated precipitate of collagen and carboxymethyl cellulose complex containing each enzyme is dispersed in the liquid.
引きつづき攪拌して、これらの沈澱を均一化した後、脱
泡を行ってそれぞれの液を深さIcmのアクリル樹脂製
容器に流しこみ、20℃で通風しながら乾燥した。These precipitates were homogenized by continuous stirring, and then defoamed, and each liquid was poured into an acrylic resin container with a depth of 1 cm, and dried at 20° C. with ventilation.
このようにして得た複合体の膜をホルムアルデヒドの0
.1係水溶液で5分間処理することにより、強化処理を
施した固定化酵素膜が得られる。The membrane of the composite thus obtained was washed with formaldehyde.
.. A strengthened immobilized enzyme membrane can be obtained by treatment with aqueous solution 1 for 5 minutes.
これらの膜の1cdの示す酵素活性(単位)はキモトリ
プシン膜28、ウレアーゼ膜6.0であった。The enzyme activities (units) exhibited by 1 cd of these membranes were chymotrypsin membrane 28 and urease membrane 6.0.
実施例 2
β−アミラーゼ、グルコアミラーゼ各400772@を
90mlの蒸溜水に溶解し、それぞれ別の容器中に入れ
、攪拌してpHを4.5に保ちながらアルカリ可溶化コ
ラーゲンの1係水溶液100mlを加える。Example 2 β-amylase and glucoamylase 400772@ each were dissolved in 90 ml of distilled water, placed in separate containers, and mixed with 100 ml of an aqueous solution of alkaline solubilized collagen while maintaining the pH at 4.5. Add.
これらの混合液をさらに充分攪拌して均一にしpHを4
.5に保ちながら、ヒアルロン酸の2係水溶液10ml
を除々に添加すると各酵素を包括したコラーゲン、ヒア
ルロン酸複合体の繊維状の凝集沈澱の分散した状態にな
る。Stir these mixtures thoroughly to make them uniform and adjust the pH to 4.
.. 10ml of hyaluronic acid dihydric aqueous solution while maintaining the
When added gradually, a fibrous aggregated precipitate of collagen and hyaluronic acid complex containing each enzyme becomes dispersed.
引きつづき攪拌を続けてこれらの沈澱を均一化した後、
ジアルデヒドスターチの1係水溶液10mlを加えて均
一化した後、脱泡を行い、各々の液を深さ1cmのアク
リル樹脂製容器に流しこみ、20℃で通風しながら乾燥
した。After continuing to stir to homogenize these precipitates,
After adding 10 ml of an aqueous solution of dialdehyde starch to homogenize the mixture, defoaming was performed, and each liquid was poured into a 1 cm deep acrylic resin container and dried at 20° C. with ventilation.
このようにして強化された固定化酵素膜が得られた。A reinforced immobilized enzyme membrane was thus obtained.
これらの膜1crAの示す酵素活性(単位)はβ−アミ
ラーゼ膜0.8、グルコアミラーゼ膜0.6であった。The enzyme activities (units) exhibited by these membranes 1crA were 0.8 for β-amylase and 0.6 for glucoamylase.
実施例 3
酵素可溶化コラーゲンの1係水溶液507111に蒸溜
水45mlを加え、攪拌しつつpHが4.0付近にある
ようにして、カルボキシメチルセルロースの1%水溶液
5mlあるいはヒアルロン酸の2係水溶液5mlを除々
に添加して、コラーゲンとカルボキシメチルセルロース
あるいはコラーゲンとヒアルロン酸の複合体を形成させ
る。Example 3 Add 45 ml of distilled water to a 1% aqueous solution of enzyme-solubilized collagen 507111, keep the pH around 4.0 while stirring, and add 5 ml of a 1% aqueous solution of carboxymethyl cellulose or 5 ml of a 2-part aqueous solution of hyaluronic acid. It is added gradually to form a complex of collagen and carboxymethyl cellulose or collagen and hyaluronic acid.
これらの複合体は液中に分散するが、これらの液を脱泡
した後、深さI Cfn.のアクリル樹脂製容器中に入
れ、20℃で通風しながら乾燥させ、コラーゲンとカル
ボキシメチルセルロースあるいはコラーゲンとヒアルロ
ン酸の結合した膜をつくる。These composites are dispersed in the liquid, but after defoaming these liquids, the depth I Cfn. The mixture is placed in an acrylic resin container and dried at 20°C with ventilation to form a film in which collagen and carboxymethylcellulose or collagen and hyaluronic acid are combined.
このようにして得た膜をキモトリプシンのトリス緩衝液
(μ−0.05,)pH8.5)の溶液(濃度1 0
mtg/ml )に5℃20時間浸漬した後、上記の緩
衝液で洗滌した。A solution of chymotrypsin in Tris buffer (μ-0.05, pH 8.5) (concentration 10) was added to the membrane thus obtained.
mtg/ml) for 20 hours at 5°C, and then washed with the above buffer.
次いでグルタールアルデヒドの0.05%溶液で硬化処
理を行って固定化キモトリプシン膜を得た。Then, a curing treatment was performed with a 0.05% solution of glutaraldehyde to obtain an immobilized chymotrypsin membrane.
この膜1cdの示す酵素活性(単位)は3.0であった
。The enzyme activity (unit) exhibited by 1 cd of this membrane was 3.0.
Claims (1)
と該マトリックス中に分散状態で存在する酵素とからな
る固定化酵素。 2 乾燥重量に基き可溶化コラーゲン100部に対して
、酸性多糖1〜40部および酵素10〜500部が存在
する特許請求の範囲第1項記載の固定化酵素。 3 固定化酵素が、フイルム状、糸状、スポンジ状、粒
状およびブロック状から選択される形状である特許請求
の範囲第2記載の固定化酵素。 4 固定化すべき酵素の安定pH領域のpHに調製した
酵素水溶液に可溶化コラーゲン水溶液と酸性多糖水溶液
との混合液を前記酵素の安定pH領域内でかつ可溶性コ
ラーゲンの等電点以下のpHで添加し、混合することに
より酵素を含有する可溶化コラーゲンー酸性多糖複合体
を凝集生成し、必要に応じて架橋することからなる固定
化酵素の製造方法。 5 可溶化コラーゲンが酵素可溶化コラーゲン、アルカ
リ可溶化コラーゲンおよび両者の混合物から選択される
特許請求の範囲第4項記載の固定化酵素の製造方法。 6 酸性多糖がホモグリカン、ヘテログリカン、グリク
ロナン、ムコ多糖、ホモグリカンの誘導体、テキストラ
ン硫酸、カラゲナンおよび高分子酸およびそれらの混合
物からなる群から選択される、特許請求の範囲第4項記
載の固定化酵素の製造方法。 7 乾燥重量に基き、可溶化コラーゲ7100部に対し
て酸性多糖1〜40部および酵素10〜500部を混合
する特許請求の範囲第4項記載の固定化酵素製造方法。 8 酵素を含有する可溶化コラーゲンー酸性多糖複合体
をアルデビド、植物性タンニン、3価の金属塩、合成揉
剤、チオ硫酸塩、高分子凝集剤および水不溶性高分子物
質の有機溶媒溶液からなる群から選択される試薬で更に
処理することからなる特許請求の範囲第4項記載の固定
化酵素の製造方法。 9 酵素を含有する可溶化コラーゲンー酸性多糖複合体
に対して紫外線照射、ガンマ線照射および40〜60℃
の加熱から選択される硬化処理を行うことからなる特許
請求の範囲第4項記載の固定化酵素の製造方法。 10 可溶性コラーゲン水溶液と酸性多糖水溶液と酸
性多糖水溶液とを可溶性コラーゲンの等電点以下のpH
で混合して可溶性コラーゲンー酸性多糖複合体を形成し
、該複合体を膨潤状態で固定化すべき酵素の活性安定p
H領域中で酵素水溶液に浸漬し、必要に応じてこの複合
体を架橋することからなる固定化酵素の製造方法。 11 可溶化コラーゲンが酵素可溶化コラーゲン、ア
ルカリ可溶化コラーゲンおよび両者の混合物から選択さ
れる特許請求の範囲第10項記載の固定化酵素の製造方
法。 12酸性多糖がホモグリカン、ヘテログリカン、グリク
ロナン、ムコ多糖、ホモグリカンの誘導体、デキストラ
ン硫酸、カラゲナンおよび高分子酸およびそれらの混合
物からなる群から選択される、特許請求の範囲第10項
記載の固定化酵素の製造方法。 13 乾燥重量に基き、可溶化コラーゲン100部に
対して酸性多糖1〜40部および酵素10〜500部を
混合する特許請求の範囲第10項記載の固定化酵素製造
方法。 14 酵素を含有する可溶化コラーゲンー酸性多糖複
合体をアルデヒド、植物性タンニン、3価の金属塩、合
成揉剤、チオ硫酸塩、高分子凝集剤および水不溶性高分
子物質の有機溶媒溶液からなる群から選択される試薬で
更に処理することからなる特許請求の範囲第10項記載
の固定化酵素の製造方法。 15 酵素を含有する可溶化コラーゲンー酸性多糖複
合体に対して紫外線照射、ガンマ線照射および40〜6
0℃の加熱から選択される硬化処理を行うことからなる
特許請求の範囲第10項記載の固定化酵素の製造方法。[Scope of Claims] 1. An immobilized enzyme comprising a matrix of solubilized collagen-acidic polysaccharide complex and an enzyme dispersed in the matrix. 2. The immobilized enzyme according to claim 1, wherein 1 to 40 parts of acidic polysaccharide and 10 to 500 parts of enzyme are present based on 100 parts of solubilized collagen based on dry weight. 3. The immobilized enzyme according to claim 2, wherein the immobilized enzyme has a shape selected from film-like, thread-like, sponge-like, granular and block-like. 4 Adding a mixture of a solubilized collagen aqueous solution and an acidic polysaccharide aqueous solution to an enzyme aqueous solution adjusted to a pH in the stable pH range of the enzyme to be immobilized at a pH within the stable pH range of the enzyme and below the isoelectric point of the soluble collagen. A method for producing an immobilized enzyme, which comprises aggregating a solubilized collagen-acidic polysaccharide complex containing the enzyme by mixing and crosslinking as necessary. 5. The method for producing an immobilized enzyme according to claim 4, wherein the solubilized collagen is selected from enzyme-solubilized collagen, alkali-solubilized collagen, and a mixture of both. 6. Immobilization according to claim 4, wherein the acidic polysaccharide is selected from the group consisting of homoglycans, heteroglycans, glycuronans, mucopolysaccharides, derivatives of homoglycans, texturan sulfate, carrageenan and polymeric acids and mixtures thereof. Enzyme production method. 7. The method for producing an immobilized enzyme according to claim 4, wherein 1 to 40 parts of acidic polysaccharide and 10 to 500 parts of enzyme are mixed with 7100 parts of solubilized collagen based on dry weight. 8 A solubilized collagen-acidic polysaccharide complex containing an enzyme is prepared from a group consisting of aldebides, vegetable tannins, trivalent metal salts, synthetic massaging agents, thiosulfates, polymer flocculants, and organic solvent solutions of water-insoluble polymer substances. 5. The method for producing an immobilized enzyme according to claim 4, which further comprises treating with a reagent selected from the following. 9. Solubilized collagen-acidic polysaccharide complex containing enzymes was irradiated with ultraviolet rays, gamma rays and 40-60°C
5. The method for producing an immobilized enzyme according to claim 4, which comprises performing a curing treatment selected from heating. 10 Soluble collagen aqueous solution, acidic polysaccharide aqueous solution, and acidic polysaccharide aqueous solution at pH below the isoelectric point of soluble collagen.
to form a soluble collagen-acidic polysaccharide complex, and stabilize the enzyme activity to immobilize the complex in a swollen state.
A method for producing an immobilized enzyme, which comprises immersing the complex in an aqueous enzyme solution in the H region, and optionally crosslinking the complex. 11. The method for producing an immobilized enzyme according to claim 10, wherein the solubilized collagen is selected from enzyme-solubilized collagen, alkali-solubilized collagen, and a mixture of both. 11. The immobilized enzyme of claim 10, wherein the 12-acidic polysaccharide is selected from the group consisting of homoglycans, heteroglycans, glycuronans, mucopolysaccharides, derivatives of homoglycans, dextran sulfate, carrageenan and polymeric acids and mixtures thereof. manufacturing method. 13. The method for producing an immobilized enzyme according to claim 10, wherein 1 to 40 parts of acidic polysaccharide and 10 to 500 parts of enzyme are mixed with 100 parts of solubilized collagen based on dry weight. 14 The solubilized collagen-acidic polysaccharide complex containing enzymes is prepared from a group consisting of aldehydes, vegetable tannins, trivalent metal salts, synthetic massaging agents, thiosulfates, polymer flocculants, and organic solvent solutions of water-insoluble polymer substances. 11. The method for producing an immobilized enzyme according to claim 10, which further comprises treating with a reagent selected from the following. 15 Ultraviolet irradiation, gamma ray irradiation and 40-6
11. The method for producing an immobilized enzyme according to claim 10, which comprises performing a curing treatment selected from heating at 0°C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5576176A JPS596638B2 (en) | 1976-05-15 | 1976-05-15 | immobilized enzyme |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5576176A JPS596638B2 (en) | 1976-05-15 | 1976-05-15 | immobilized enzyme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52139783A JPS52139783A (en) | 1977-11-21 |
| JPS596638B2 true JPS596638B2 (en) | 1984-02-13 |
Family
ID=13007818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5576176A Expired JPS596638B2 (en) | 1976-05-15 | 1976-05-15 | immobilized enzyme |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS596638B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0614020B2 (en) * | 1987-05-29 | 1994-02-23 | 神崎製紙株式会社 | Enzyme electrode activation method |
| CA2140053C (en) * | 1994-02-09 | 2000-04-04 | Joel S. Rosenblatt | Collagen-based injectable drug delivery system and its use |
-
1976
- 1976-05-15 JP JP5576176A patent/JPS596638B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS52139783A (en) | 1977-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Krajewska et al. | Urease immobilized on chitosan membrane: preparation and properties | |
| Elçin | Encapsulation of urease enzyme in xanthan-alginate spheres | |
| Chan et al. | Semisynthesis of a controlled stimuli-responsive alginate hydrogel | |
| Alatawi et al. | Amino functionalization of carboxymethyl cellulose for efficient immobilization of urease | |
| JPS6221513B2 (en) | ||
| JPS5912275B2 (en) | Improved methods for immobilization of biologically active substances | |
| Husain et al. | Entrapment of concanavalin A‐glycoenzyme complexes in calcium alginate gels | |
| JPS59113889A (en) | Preparation of immobilized enzyme or immobilized microbial cell | |
| Wasserman et al. | High‐yield method for immobilization of enzymes | |
| US3977941A (en) | Protein-enzyme complex membranes | |
| Costa et al. | Immobilisation of catalase on the surface of biodegradable starch-based polymers as a way to change its surface characteristics | |
| Boncooğlu | Urease immobilized poly (AAm-AGE) cryogel for depletion of urea from human serum | |
| Nussinovitch | Bead formation, strengthening, and modification | |
| US4092219A (en) | Preparation of enzyme-membrane complexes | |
| JPS596638B2 (en) | immobilized enzyme | |
| JPS5934112B2 (en) | Immobilized enzyme and its production method | |
| JPS5946594B2 (en) | Immobilized biologically active substance and its production method | |
| US5093253A (en) | Method for microbial immobilization by entrapment in gellan gum | |
| US4601981A (en) | Enzymatically active protein-enzyme complex membranes | |
| Kurokawa | Entrap-immobilization of enzyme on composite gel fibre using a gel formation of cellulose acetate and metal (Ti, Zr) alkoxide | |
| RU2788455C1 (en) | Method for obtaining a composite preparation of papain and sodium alginate in the form of a thick solution | |
| JPS61111686A (en) | Preparation of immobilized enzyme | |
| DD294729A5 (en) | PROCESS FOR THE PRODUCTION OF IMMOBILISATES WITH BIOLOGICALLY ACTIVE, MACROMOLECULAR COMPOUNDS | |
| JPH02245189A (en) | Immobilized physiologically active substance and production thereof | |
| Panpae et al. | Development of Urease immobilization using poly (acrylonitrile)/chitosan composite materials |